P2X7 Receptor Signaling Pathway as a Therapeutic Target for Neurodegenerative Diseases

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Archivum Immunologiae et Therapiae Experimentalis

• Publication date

  2010-02-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00005-010-0069-yPMID 20143170
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models.

  2009cited by this paper
• The P2X7 Receptor Drives Microglial Activation and Proliferation: A Trophic Role for P2X7R Pore

  2009cited by this paper
• Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury

  2009cited by this paper
• Activation of P2X7 receptors induces CCL3 production in microglial cells through transcription factor NFAT

  2009cited by this paper
• Modulation of the ATP-lnduced release and processing of IL-1beta in microglial cells.

  2009cited by this paper
• Altered P2X7‐receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration

  2009cited by this paper
• The Activation of P2X7 Receptor Impairs Lysosomal Functions and Stimulates the Release of Autophagolysosomes in Microglial Cells1

  2009cited by this paper
• Activation of Microglia by Amyloid β Requires P2X7 Receptor Expression1

  2009cited by this paper
• Inhibition of P2X7 receptors by divalent cations: old action and new insight

  2009cited by this paper
• Cellular pathogenesis in prion diseases.

  2008cited by this paper
• Inflammatory Response in the Hippocampus of PS1M146L/APP751SL Mouse Model of Alzheimer's Disease: Age-Dependent Switch in the Microglial Phenotype from Alternative to Classic

  2008cited by this paper
• Block of purinergic P2X7 receptor is neuroprotective in an animal model of Alzheimer's disease

  2008cited by this paper
• Lysophospholipids and ATP Mutually Suppress Maturation and Release of IL-1β in Mouse Microglial Cells Using a Rho-Dependent Pathway1

  2008cited by this paper
• Inhibitors of metabolism rescue cell death in Huntington's disease models

  2007cited by this paper
• Prion infection correlates with hypersensitivity of P2X7 nucleotide receptor in a mouse microglial cell line

  2007cited by this paper
• P2X7 Receptor Blockade Prevents ATP Excitotoxicity in Oligodendrocytes and Ameliorates Experimental Autoimmune Encephalomyelitis

  2007cited by this paper
• Lysophosphatidylcholine potentiates Ca2+ influx, pore formation and p44/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells

  2007cited by this paper
• International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy

  2006cited by this paper
• Microglial Cell Line Established from Prion Protein-Overexpressing Mice Is Susceptible to Various Murine Prion Strains

  2006cited by this paper
• P2X7 receptors: Properties and relevance to CNS function

  2006cited by this paper
• Upregulated Expression of Purinergic P2X7 Receptor in Alzheimer Disease and Amyloid-&bgr; Peptide-Treated Microglia and in Peptide-Injected Rat Hippocampus

  2006cited by this paper
• Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons.

  2006cited by this paper
• A role for P2X7 in microglial proliferation

  2006cited by this paper
• Chaperone and anti‐chaperone: Two‐faced synuclein as stimulator of synaptic evolution

  2006cited by this paper
• The P2X7 Receptor: A Key Player in IL-1 Processing and Release1

  2006cited by this paper
• Microglia Biology in Health and Disease

  2006cited by this paper
• Inhibitory effects of U73122 and U73343 on Ca2+ influx and pore formation induced by the activation of P2X7 nucleotide receptors in mouse microglial cell line.

  2005cited by this paper
• Reanalysis of P2X7 Receptor Expression in Rodent Brain

  2004cited by this paper
• Production and Release of Neuroprotective Tumor Necrosis Factor by P2X7 Receptor-Activated Microglia

  2004cited by this paper
• P2X7 Receptor-Mediated Release of Excitatory Amino Acids from Astrocytes

  2003cited by this paper
• P2X7 nucleotide receptor activation enhances IFNγ‐induced type II nitric oxide synthase activity in BV‐2 microglial cells

  2003cited by this paper
• P2X7 Mediates Superoxide Production in Primary Microglia and Is Up-regulated in a Transgenic Mouse Model of Alzheimer's Disease*

  2003cited by this paper
• Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice.

  2003cited by this paper
• Molecular physiology of P2X receptors.

  2002influential reference
• Origin of microglia

  2001cited by this paper
• Cutting Edge: The Nucleotide Receptor P2X7 Contains Multiple Protein- and Lipid-Interaction Motifs Including a Potential Binding Site for Bacterial Lipopolysaccharide1

  2001cited by this paper
• Neuronal P2X receptors: localisation and functional properties

  2000cited by this paper
• Alpha‐synuclein in Lewy Body Disease and Alzheimer's Disease

  1999cited by this paper
• Cytolytic P2X purinoceptors

  1998cited by this paper
• Extracellular ATP Activates Transcription Factor NF-κB through the P2Z Purinoreceptor by Selectively Targeting NF-κB p65 (RelA)

  1997cited by this paper
• Purinergic Modulation of Interleukin-1β Release from Microglial Cells Stimulated with Bacterial Endotoxin

  1997cited by this paper
• ATP-mediated cytotoxicity in microglial cells.

  1997cited by this paper
• Mouse microglial cells express a plasma membrane pore gated by extracellular ATP.

  1996cited by this paper
• Amyloid β-Protein and the Genetics of Alzheimer's Disease*

  1996cited by this paper
• The Cytolytic P2Z Receptor for Extracellular ATP Identified as a P2X Receptor (P2X7)

  1996cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• Molecular biology of prion diseases

  1991cited by this paper
• Lifetime toxicity/carcinogenicity studies of FD & C Blue No. 1 (brilliant blue FCF) in rats and mice.

  1990cited by this paper
• Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

  1983cited by this paper
• Absorption and excretion of certain triphenylmethane colors in rats and dogs.

  1955cited by this paper

• Neuroinflammation in epilepsy: Mitochondrial connections and therapeutic targets

  2026cites this paper
• P2RX7 modulates the function of human microglia-like cells and mediates the association of IL18 with Alzheimer’s disease traits

  2025cites this paper
• Possible Roles for Purinergic Receptor P2RX4 in Breast and Prostate Cancers

  2025cites this paper
• Inhibition of P2X7R Activation Ameliorates Damage to the Corneas and Corneal Nerves of Rats with Streptozotocin (STZ)-Induced Type 1 Diabetes

  2025cites this paper
• The cellular distribution of P2X7, P2Y6, and P2Y12 during or after pilocarpine-induced status epilepticus and literature review

  2024cites this paper
• Purinergic Receptor (P2X7R): A Promising Anti-Parkinson’s Drug Target

  2024cites this paper
• Neuronal regulated cell death in aging-related neurodegenerative diseases: key pathways and therapeutic potentials

  2024cites this paper
• Techniques for evaluating the ATP-gated ion channel P2X7 receptor function in macrophages and microglial cells.

  2024cites this paper
• IL-1RA Disrupts ATP Activation of P2RX7 in Human Monocyte-Derived Microglia-like Cells

  2024cites this paper
• P2X7 receptor: A receptor closely linked with sepsis-associated encephalopathy

  2024cites this paper
• Purinergic signaling: A gatekeeper of blood-brain barrier permeation

  2023cites this paper
• Naphthoquinones as a Promising Class of Compounds for Facing the Challenge of Parkinson’s Disease

  2023cites this paper
• Improved syntheses of P2X7 ligands based on substituted benzyl amide of pyroglutamic acid motif labelled with iodine-123 or iodine-125

  2023cites this paper
• P2X7 purinergic receptor: A potential target in heart diseases (Review).

  2023cites this paper
• Simulated hypoxia modulates P2X7 receptor function in mice peritoneal macrophages.

  2022cites this paper
• Aluminum induces neuroinflammation via P2X7 receptor activating NLRP3 inflammasome pathway.

  2022cites this paper
• HDAC3 Inhibitor RGFP966 Ameliorated Neuroinflammation in the Cuprizone-Induced Demyelinating Mouse Model and LPS-Stimulated BV2 Cells by Downregulating the P2X7R/STAT3/NF-κB65/NLRP3 Activation.

  2022cites this paper
• Ligand-gated ion channel P2X7 regulates hypoxia-induced factor-1α mediated pain induced by dental pulpitis in the medullary dorsal horn

  2022cites this paper
• Modulation of microglia activation and Alzheimer's disease: CX3 chemokine ligand 1/CX3CR and P2X7R signaling

  2021cites this paper
• The Repertoire of Small-Molecule PET Probes for Neuroinflammation Imaging: Challenges and Opportunities beyond TSPO.

  2021cites this paper
• P2X7 receptor in multifaceted cellular signaling and its relevance as a potential therapeutic target in different diseases.

  2021cites this paper
• Alzheimer and Purinergic Signaling: Just a Matter of Inflammation?

  2021cites this paper
• From purines to purinergic signalling: molecular functions and human diseases

  2021cites this paper
• Minimally invasive quantification of cerebral P2X7R occupancy using dynamic [18F]JNJ-64413739 PET and MRA-driven image derived input function

  2021cites this paper
• Emerging Molecular Mechanisms of Neuroinflammation in Seizure Disorders

  2021cites this paper
• Inflammation and reactive oxygen species as disease modifiers in epilepsy.

  2020cites this paper
• Purinergic Signaling in Spinal Cord Injury Induced-Neurogenic Bladder: A Mini- Review Study

  2020cites this paper
• The Role of NMDA Receptors in the Effect of Purinergic P2X7 Receptor on Spontaneous Seizure Activity in WAG/Rij Rats With Genetic Absence Epilepsy

  2020cites this paper
• Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease.

  2019cites this paper
• Nucleotides regulate the common molecular mechanisms that underlie neurodegenerative diseases; Therapeutic implications.

  2019cites this paper
• Diabetes‐induced damage of gastric nitric oxide neurons mediated by P2X7R in diabetic mice

  2019cites this paper
• Calcium-Handling Defects and Neurodegenerative Disease.

  2019cites this paper
• Age-specific effects of P2X7 receptors on olfactory function in mice.

  2019cites this paper
• Characterization of soluble CD39 (SolCD39/NTPDase1) from PiggyBac nonviral system as a tool to control the nucleotides level.

  2019cites this paper
• Regulation of P2X7 receptor expression and function in the brain.

  2019cites this paper
• Crosstalk between Oxidative Stress and Tauopathy

  2019cites this paper
• Coloring the Truth: Color Additives in Nutrition and Health

  2018cites this paper
• Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy

  2018cites this paper
• Ethanol differentially modulates P2X4 and P2X7 receptor activity and function in BV2 microglial cells

  2018cites this paper
• P2X7 Receptor-Associated Programmed Cell Death in the Pathophysiology of Hemorrhagic Stroke

  2018cites this paper
• Pore forming channels as a drug delivery system for photodynamic therapy in cancer associated with nanoscintillators

  2018cites this paper
• Brilliant Blue G protects against photoreceptor injury in a murine endotoxin-induced uveitis model.

  2018cites this paper
• Administration of an antagonist of P2X7 receptor to EAE rats prevents a decrease of expression of claudin-5 in cerebral capillaries

  2018cites this paper
• Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO

  2018cites this paper
• 18F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446

  2018cites this paper
• Role of purinergic receptors in the Alzheimer’s disease

  2018cites this paper
• P2X7 Receptor Antagonist A804598 Inhibits Inflammation in Brain and Liver in C57BL/6J Mice Exposed to Chronic Ethanol and High Fat Diet

  2018cites this paper
• Calcium dysregulation in mononuclear cells from patients with Amyotrophic lateral sclerosis

  2017cites this paper
• Presenilin 2 deficiency facilitates Aβ-induced neuroinflammation and injury by upregulating P2X7 expression

  2017cites this paper
• The effect of wulongdan on neuroinflammation factors and the expression of P2X7 receptor in the SAH rats

  2017cites this paper
• Interactions Between Amyloid-beta and Microglial Cells

  2017cites this paper
• P2X7 receptor antagonists: a patent review (2010–2015)

  2017cites this paper
• Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease

  2016cites this paper
• Effects of perinatal exposure to lead (Pb) on purine receptor expression in the brain and gliosis in rats tolerant to morphine analgesia.

  2016cites this paper
• Oral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents 
Neuronal Loss in APPSwDI/NOS2-/- Mouse Model

  2016cites this paper
• Preclinical Evaluation of a P2X7 Receptor–Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates

  2016cites this paper
• Effect of axotomy and 17β-estradiol on P2X7 receptor expression pattern in the hypoglossal nucleus of ovariectomized mice.

  2016cites this paper
• Protective effects of P2X7 receptor deletion on aging-related memory alterations

  2016influential citation
• Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection.

  2016cites this paper
• P2X ion channel receptors and inflammation

  2016cites this paper
• Small molecules with anti-inflammatory properties in clinical development.

  2016cites this paper
• An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.

  2016cites this paper
• DOENÇA DE ALZHEIMER

  2016cites this paper
• P2X7 receptor is critical in α-synuclein--mediated microglial NADPH oxidase activation.

  2015cites this paper
• Upregulation of Runt‐Related Transcription Factor‐2 Through CCAAT Enhancer Binding Protein‐β Signaling Pathway in Microglial BV‐2 Cells Exposed to ATP

  2015cites this paper
• Nanoparticle-encapsulated P2X₇ receptor antagonist in a pH-sensitive polymer as a potential local drug delivery system to acidic inflammatory environments.

  2015cites this paper
• P2Y receptors in Alzheimer's disease

  2015cites this paper
• Synthesis of [(11)C]GSK1482160 as a new PET agent for targeting P2X(7) receptor.

  2015cites this paper
• ATP-induced cellular stress and mitochondrial toxicity in cells expressing purinergic P2X7 receptor

  2015cites this paper
• An Improved Method for P2X7R Antagonist Screening

  2015cites this paper
• P2X7 receptor antagonists protect against N-methyl-D-aspartic acid-induced neuronal injury in the rat retina.

  2015cites this paper
• Chronic ethanol exposure combined with high fat diet up-regulates P2X7 receptors that parallels neuroinflammation and neuronal loss in C57BL/6J mice.

  2015cites this paper
• Activation and Inhibition of Pannexin 1 Channels

  2015cites this paper
• Role of Autophagy in P2X7 Receptor-Mediated Maturation and Unconventional Secretion of IL-1β in Microglia

  2015cites this paper
• Brilliant Blue G improves cognition in an animal model of Alzheimer's disease and inhibits amyloid-β-induced loss of filopodia and dendrite spines in hippocampal neurons.

  2014influential citation
• Constitutive and functional expression of runt-related transcription factor-2 by microglial cells.

  2014cites this paper
• Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis

  2014cites this paper
• The P2X7 Receptor in AMD

  2014cites this paper
• P2X and P2Y Receptors—Role in the Pathophysiology of the Nervous System

  2014cites this paper
• Synthesis and initial preclinical evaluation of the P2X7 receptor antagonist [¹¹C]A-740003 as a novel tracer of neuroinflammation.

  2014cites this paper
• The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease

  2014cites this paper
• Modulation des activités du récepteur purinergique P2X7 au cours de l’activation des lymphocytes T

  2014cites this paper
• The P2X7 Receptor: A Key Player in Immune-Mediated Bone Loss?

  2014cites this paper
• PET radioligands for in vivo visualization of neuroinflammation.

  2014cites this paper
• Gain and loss of function of P2X7 receptors: mechanisms, pharmacology and relevance to diabetic neuropathic pain

  2014cites this paper
• This information is current as Amyotrophic Lateral Sclerosis SOD1-G93A Microglia Model of Receptor in the 7 Dysregulated by the P2X The NADPH Oxidase Pathway Is

  2013cites this paper
• Brilliant Blue G: what a little more colour can be.

  2013cites this paper
• Neurotransmitters and microglial-mediated neuroinflammation.

  2013cites this paper
• Silencing of the P2X(7) receptor enhances amyloid-β phagocytosis by microglia.

  2013cites this paper
• Patterns of histone acetylation as targets for novel therapeutic approaches in neurological diseases

  2013cites this paper
• Microglia during development and aging.

  2013cites this paper
• Brilliant Blue G: What a Little More Colour Can Be

  2013cites this paper
• The NADPH Oxidase Pathway Is Dysregulated by the P2X7 Receptor in the SOD1-G93A Microglia Model of Amyotrophic Lateral Sclerosis

  2013cites this paper
• Flow Synthesis and Biological Studies of an Analgesic Adamantane Derivative That Inhibits P2X7-Evoked Glutamate Release.

  2013cites this paper
• P2X7 receptor activation mediates retinal ganglion cell death in a human retina model of ischemic neurodegeneration.

  2013cites this paper
• The food dye FD&C Blue No. 1 is a selective inhibitor of the ATP release channel Panx1

  2013cites this paper
• Mechanisms of behavioral, atopic, and other reactions to artificial food colors in children.

  2013cites this paper
• P2X7 receptors in cerebral ischemia

  2013cites this paper
• Natural compounds with P2X7 receptor-modulating properties

  2013cites this paper
• Triphenylmethane Dye Activation of Beta-Arrestin

  2013cites this paper